UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Hepatotoxicity of Antiretroviral Drugs Is Reduced after Successful Treatment of Chronic Hepatitis C in HIV-Infected Patients

The Journal of infectious diseases, 2007-09, Vol.196 (5), p.670-676

2007

Volltextzugriff (PDF)

Update on HIV/HCV Coinfection

Current HIV/AIDS reports, 2013-09, Vol.10 (3), p.226-234

2013

Volltextzugriff (PDF)

Influence of Interleukin-28B Single-Nucleotide Polymorphisms on Progression to Liver Cirrhosis in Human Immunodeficiency Virus-Hepatitis C Virus-Coinfected Patients Receiving Antiretroviral Therapy

The Journal of infectious diseases, 2011-06, Vol.203 (11), p.1629-1636

2011

Volltextzugriff (PDF)

Noncirrhotic portal hypertension in HIV infection

Current opinion in infectious diseases, 2011-02, Vol.24 (1), p.12-18

2011

Volltextzugriff (PDF)

Hepatitis B in HIV-Infected Patients

Clinics in liver disease, 2013-08, Vol.17 (3), p.489-501

2013

Volltextzugriff (PDF)

Genetic Determinants of Idiopathic Noncirrhotic Portal Hypertension in HIV-Infected Patients

Clinical infectious diseases, 2013-04, Vol.56 (8), p.1117-1122

2013

Volltextzugriff (PDF)

Very late relapse after discontinuation of antiviral therapy for chronic hepatitis C

Antiviral therapy, 2013-01, Vol.18 (8), p.1033-1035

2013

Volltextzugriff (PDF)

Viral hepatitis and HIV co-infection

Antiviral research, 2010, Vol.85 (1), p.303-315

2010

Volltextzugriff (PDF)

Treatment of Hepatitis C in Patients Infected with Human Immunodeficiency Virus in the Direct-Acting Antiviral Era

Infectious disease clinics of North America, 2012-12, Vol.26 (4), p.931-948

2012

Volltextzugriff (PDF)

Hepatitis Delta Is a Major Determinant of Liver Decompensation Events and Death in HIV-Infected Patients

Clinical infectious diseases, 2014-06, Vol.58 (11), p.1549-1553

2014

Volltextzugriff (PDF)

Antiretroviral-associated portal hypertension : a new clinical condition? Prevalence, predictors and outcome

Antiviral therapy, 2008, Vol.13 (1), p.103-107

2008

Volltextzugriff (PDF)

New Drug Targets for Hepatitis C and Other Flaviviridae Viruses

Infectious disorders drug targets, 2009-04, Vol.9 (2), p.133-147

2009

Volltextzugriff (PDF)

Directly acting antivirals against hepatitis C virus

Journal of antimicrobial chemotherapy, 2011-08, Vol.66 (8), p.1673-1686

2011

Volltextzugriff (PDF)

Management and treatment of chronic hepatitis C in HIV patients

Seminars in liver disease, 2012-05, Vol.32 (2), p.138-146

2012

Volltextzugriff (PDF)

Glomerular filtration (GF) determined by creatinine clearance (CCR) in 24 hours urine and cockcroft & gault (cg) and modification of diet in renal disease (MDRD) equations in a large cohort of HIV+ patients

Retrovirology, 2010-05, Vol.7 (S1), p.P76-P76, Article P76

2010

Volltextzugriff (PDF)

Tenofovir (TDF) containing first-line HAART is associated with changes in plasma parameters suggestive of increased bone resorption

Retrovirology, 2010-05, Vol.7 (S1), p.O13-O13, Article O13

2010

Volltextzugriff (PDF)

Pharmacokinetics of new oral hepatitis C antiviral drugs

Expert opinion on drug metabolism & toxicology, 2013-01, Vol.9 (1), p.5-16

2013

Volltextzugriff (PDF)

Treatment failure with new hepatitis C drugs

Expert opinion on pharmacotherapy, 2012-02, Vol.13 (3), p.313-323

2012

Volltextzugriff (PDF)

Hepatitis C therapy with HCV NS5B polymerase inhibitors

Expert opinion on pharmacotherapy, 2013-06, Vol.14 (9), p.1161-1170

2013

Volltextzugriff (PDF)

Hepatitis in the New IAS-USA Panel Antiretroviral Treatment Guidelines

AIDS reviews, 2010-09, Vol.12 (3)

Vispo, E

2010

Volltextzugriff (PDF)

Management of hepatitis B virus co-infection on and off antiretroviral therapy

Current HIV/AIDS reports, 2008-05, Vol.5 (2), p.86-93

2008

Volltextzugriff (PDF)

Pharmacogenetics of hepatitis C

Journal of antimicrobial chemotherapy, 2012-03, Vol.67 (3), p.523-529

2012

Volltextzugriff (PDF)

Scaling up epidemics of acute hepatitis C and syphilis in HIV-infected men who have sex with men in Spain

Liver international, 2013-10, Vol.33 (9), p.1357-1362

2013

Volltextzugriff (PDF)

Prevalence of natural polymorphisms at the HCV NS5A gene associated with resistance to daclatasvir, an NS5A inhibitor

Antiviral therapy, 2012-01, Vol.17 (5), p.921-926

2012

Volltextzugriff (PDF)

Impact of IL28B gene polymorphisms on interferon-λ3 plasma levels during pegylated interferon-α/ribavirin therapy for chronic hepatitis C in patients coinfected with HIV

Journal of antimicrobial chemotherapy, 2012-05, Vol.67 (5), p.1246-1249

2012

Volltextzugriff (PDF)

1 – 25 von 102

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieAids

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(85)
Mit Volltextzugriff
(68)

Publikationsform

Artikel
(98)
Berichte
(4)

Sprache

Englisch
(98)
Spanisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Hepatotoxicity of Antiretroviral Drugs Is Reduced after Successful Treatment of Chronic Hepatitis C in HIV-Infected Patients

Update on HIV/HCV Coinfection

Influence of Interleukin-28B Single-Nucleotide Polymorphisms on Progression to Liver Cirrhosis in Human Immunodeficiency Virus-Hepatitis C Virus-Coinfected Patients Receiving Antiretroviral Therapy

Noncirrhotic portal hypertension in HIV infection

Hepatitis B in HIV-Infected Patients

Genetic Determinants of Idiopathic Noncirrhotic Portal Hypertension in HIV-Infected Patients

Very late relapse after discontinuation of antiviral therapy for chronic hepatitis C

Viral hepatitis and HIV co-infection

Treatment of Hepatitis C in Patients Infected with Human Immunodeficiency Virus in the Direct-Acting Antiviral Era

Hepatitis Delta Is a Major Determinant of Liver Decompensation Events and Death in HIV-Infected Patients

Antiretroviral-associated portal hypertension : a new clinical condition? Prevalence, predictors and outcome

New Drug Targets for Hepatitis C and Other Flaviviridae Viruses

Directly acting antivirals against hepatitis C virus

Management and treatment of chronic hepatitis C in HIV patients

Glomerular filtration (GF) determined by creatinine clearance (CCR) in 24 hours urine and cockcroft & gault (cg) and modification of diet in renal disease (MDRD) equations in a large cohort of HIV+ patients

Tenofovir (TDF) containing first-line HAART is associated with changes in plasma parameters suggestive of increased bone resorption

Pharmacokinetics of new oral hepatitis C antiviral drugs

Treatment failure with new hepatitis C drugs

Hepatitis C therapy with HCV NS5B polymerase inhibitors

Hepatitis in the New IAS-USA Panel Antiretroviral Treatment Guidelines

Management of hepatitis B virus co-infection on and off antiretroviral therapy

Pharmacogenetics of hepatitis C

Scaling up epidemics of acute hepatitis C and syphilis in HIV-infected men who have sex with men in Spain

Prevalence of natural polymorphisms at the HCV NS5A gene associated with resistance to daclatasvir, an NS5A inhibitor

Impact of IL28B gene polymorphisms on interferon-λ3 plasma levels during pegylated interferon-α/ribavirin therapy for chronic hepatitis C in patients coinfected with HIV

Aktive Filter

Suchergebnisse filtern